Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
-
14 Sep 21 DRS/A Draft registration statement (amended)
- 21 Jul 21 DRS/A Draft registration statement (amended)
- 8 Jun 21 DRS/A Draft registration statement (amended)
- 23 Mar 20 DRS/A Draft registration statement (amended)
- 12 Feb 20 DRS/A Draft registration statement (amended)
- 27 Dec 19 DRS Draft registration statement
AEON Biopharma similar filings
Filing view
External links
Exhibit 99.2
Consent to be Named as a Director Nominee
In connection with the filing of a registration statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”) by AEON Biopharma, Inc., a Delaware corporation (the “Company”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company in such registration statement and any amendments and supplements thereto, and to the filing of this consent as an exhibit to such registration statement and any amendments and supplements thereto.